UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

What is CD4+CD56+ malignancy and how should it be treated?

Bone marrow transplantation (Basingstoke), 2003-10, Vol.32 (7), p.637-646

2003

Link zum Volltext

Verfügbarkeit prüfen

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2006-02, Vol.24 (6), p.961-968

2006

Link zum Volltext

Verfügbarkeit prüfen

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

The American journal of pathology, 2004-07, Vol.165 (1), p.159-166

2004

Link zum Volltext

Verfügbarkeit prüfen

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Blood, 2012-12, Vol.120 (24), p.4795-4801

2012

Link zum Volltext

Verfügbarkeit prüfen

Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms

British journal of haematology, 2007-01, Vol.136 (2), p.286-293

2007

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

The New England journal of medicine, 2004-11, Vol.351 (21), p.2159-2169

2004

Link zum Volltext

Verfügbarkeit prüfen

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

The New England journal of medicine, 2002-06, Vol.346 (25), p.1937-1947

2002

Link zum Volltext

Verfügbarkeit prüfen

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

American journal of hematology, 2001-07, Vol.67 (3), p.172-178

2001

Link zum Volltext

Verfügbarkeit prüfen

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

Blood, 2006-07, Vol.108 (1), p.311-318

2006

Link zum Volltext

Verfügbarkeit prüfen

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3835-3849

1999

Link zum Volltext

Verfügbarkeit prüfen

Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2486-2492

1999

Link zum Volltext

Verfügbarkeit prüfen

Up-Regulation of BOB.1/OBF.1 Expression in Normal Germinal Center B Cells and Germinal Center-Derived Lymphomas

The American journal of pathology, 2000-02, Vol.156 (2), p.501-507

2000

Link zum Volltext

Verfügbarkeit prüfen

Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type

The American journal of surgical pathology, 1995-05, Vol.19 (5), p.571-575

1995

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of follicular lymphoma with monocytoid B cells

Human pathology, 1999, Vol.30 (3), p.263-268

1999

Link zum Volltext

Verfügbarkeit prüfen

Polymorphous high grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas. Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies

The American journal of surgical pathology, 1994-09, Vol.18 (9), p.931-937

1994

Link zum Volltext

Verfügbarkeit prüfen

Primary cerebral malignant non-Hodgkin's lymphomas : a retrospective clinical study

Journal of neurology, 1992-03, Vol.239 (3), p.117-124

1992

Link zum Volltext

Verfügbarkeit prüfen

Early stage of human sympathetic ophthalmia. Histologic and immunopathologic findings

Archives of ophthalmology (1960), 1984-09, Vol.102 (9), p.1353

1984

Link zum Volltext

Verfügbarkeit prüfen

HTLV‐positive and ‐negative T‐cell lymphomas. Morphological and immunohistochemical differences between european and HTLV‐positive japanese T‐cell lymphomas

International journal of cancer, 1985-01, Vol.35 (1), p.65-72

1985

Link zum Volltext

Verfügbarkeit prüfen

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

Nature genetics, 2012-12, Vol.44 (12), p.1316-1320

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 158

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(148)

Publikationsform

Artikel
(158)

Sprache

Englisch
(158)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Medical Sciences
(151)
Humans
(147)
Science & Technology
(144)
Life Sciences & Biomedicine
(143)
Hematologic And Hematopoietic Diseases
(87)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(85)
Male
(69)
Female
(68)
Pathology
(61)
Middle Aged
(58)
Adult
(53)
Aged
(50)
Oncology
(40)
Immunohistochemistry
(36)
Tumors
(32)
Hematology
(31)
Adolescent
(24)
Aged, 80 And Over
(22)
Immunophenotyping
(21)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What is CD4+CD56+ malignancy and how should it be treated?

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma

BCL2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases

Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

Systemic anaplastic large‐cell lymphoma: Results from the non‐Hodgkin's lymphoma classification project

Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma

Up-Regulation of BOB.1/OBF.1 Expression in Normal Germinal Center B Cells and Germinal Center-Derived Lymphomas

Primary low-grade hepatic B-cell lymphoma of mucosa-associated lymphoid tissue (MALT)-type

Clinical significance of follicular lymphoma with monocytoid B cells

Polymorphous high grade B cell lymphoma is the predominant type of spontaneous primary cerebral malignant lymphomas. Histological and immunomorphological evaluation of computed tomography-guided stereotactic brain biopsies

Primary cerebral malignant non-Hodgkin's lymphomas : a retrospective clinical study

Early stage of human sympathetic ophthalmia. Histologic and immunopathologic findings

HTLV‐positive and ‐negative T‐cell lymphomas. Morphological and immunohistochemical differences between european and HTLV‐positive japanese T‐cell lymphomas

Point mutations and genomic deletions in CCND1 create stable truncated cyclin dl mRNAs that are associated with increased proliferation rate and shorter survival

Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group

Aktive Filter

Suchergebnisse filtern